<DOC>
	<DOCNO>NCT00852631</DOCNO>
	<brief_summary>The purpose study evaluate efficacy Seroquel XR schizophrenia patient acute worsen symptom . Consequently , ass whether study drug safe acceptable daily dose basis , orally give , 600 mg day 42 day .</brief_summary>
	<brief_title>Seroquel XR Adults With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patient meet DSMIV criterion schizophrenia Patient PANSS total score ≥ 70 baseline Patient CGIS score ≥ 4 ( moderately ill ) baseline Patient healthy basis physical examination vital sign baseline Positive urine drug screen Opiates , amphetamine , barbiturate , cocaine , cannabis , ecstasy abuse Has history neuroleptic malignant syndrome , seropositive antiHIV , hepatitis B C virus antigen Patient unstable inadequately treat Diabetes Mellitus Use potent cytochrome P450 inhibitor inducer within 14 day baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Quetiapine efficacy schizophrenia</keyword>
</DOC>